KA
AMGN icon

Kintegral Advisory’s Amgen AMGN Stock Holding History

Kintegral Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4M Sell
29,489
-1,308
-4% -$466K 0.98% 21
2025
Q4 		$10.1M Sell
30,797
-842
-3% -$267K 0.85% 23
2025
Q3 		$8.93M Sell
31,639
-142
-0.4% -$41.2K 0.76% 24
2025
Q2 		$8.87M Sell
31,781
-48
-0.2% -$13.6K 0.81% 26
2025
Q1 		$9.92M Sell
31,829
-106
-0.3% -$31.3K 1% 20
2024
Q4 		$8.32M Sell
31,935
-1,488
-4% -$441K 0.79% 24
2024
Q3 		$10.8M Sell
33,423
-438
-1% -$143K 0.99% 19
2024
Q2 		$10.6M Buy
33,861
+3,917
+13% +$1.15M 1.01% 15
2024
Q1 		$8.51M Sell
29,944
-93
-0.3% -$27.2K 0.85% 24
2023
Q4 		$8.65M Sell
30,037
-191
-0.6% -$52K 0.96% 19
2023
Q3 		$8.12M Sell
30,228
-18
-0.1% -$4.49K 1% 18
2023
Q2 		$6.72M Hold
30,246
– – 0.8% 28
2023
Q1 		$7.31M Sell
30,246
-1,625
-5% -$399K 0.94% 21
2022
Q4 		$8.37M Buy
31,871
+8,791
+38% +$2.36M 1.11% 16
2022
Q3 		$5.2M Hold
23,080
– – 0.72% 27
2022
Q2 		$5.62M Buy
23,080
+489
+2% +$120K 0.73% 29
2022
Q1 		$5.46M Buy
22,591
+505
+2% +$116K 0.6% 35
2021
Q4 		$4.97M Hold
22,086
– – 0.51% 46
2021
Q3 		$4.7M Hold
22,086
– – 0.55% 40
2021
Q2 		$5.38M Hold
22,086
– – 0.64% 34
2021
Q1 		$5.5M Hold
22,086
– – 0.71% 32
2020
Q4 		$5.08M Hold
22,086
– – 0.69% 31
2020
Q3 		$5.61M Sell
22,086
-711
-3% -$176K 0.85% 26
2020
Q2 		$5.38M Hold
22,797
– – 0.86% 26
2020
Q1 		$4.62M Buy
22,797
+2,550
+13% +$557K 0.9% 24
2019
Q4 		$4.88M Hold
20,247
– – 0.89% 20
2019
Q3 		$3.92M Hold
20,247
– – 0.78% 29
2019
Q2 		$3.73M Hold
20,247
– – 0.76% 31
2019
Q1 		$3.85M Buy
20,247
+1,636
+9% +$312K 0.81% 26
2018
Q4 		$3.62M Buy
+18,611
New +$3.63M 1.07% 22

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Kintegral Advisory's AMGN Position: Q1 2026 in Review

Kintegral Advisory reduced its Amgen (AMGN) stake by 4.2% in Q1 2026, selling an estimated $466K and leaving 29,489 shares worth $10.4M. The position accounts for 0.98% of the portfolio, ranked #21.

Kintegral Advisory first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $10.8M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kintegral Advisory held 29,489 shares of Amgen worth $10.4M as of Q1 2026.
  • Kintegral Advisory sold 1,308 Amgen shares in Q1 2026, an estimated $466K.
  • Amgen made up 0.98% of Kintegral Advisory's portfolio in Q1 2026, its #21 holding.
  • Kintegral Advisory first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Kintegral Advisory's Amgen position peaked at $10.8M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kintegral Advisory's 13F filing for Q1 2026, filed 14 May 2026.